missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Ly-108 Monoclonal Antibody (eBio13G3-19D (13G3-19D)), APC, eBioscience™
GREENER_CHOICE

Mouse Monoclonal Antibody

406.00 CHF

Spezifikation

Antigen Ly-108
Klon eBio13G3-19D (13G3-19D)
Konzentration 0.2 mg/mL
Inhalt und Lagerung 4°C, store in dark, DO NOT FREEZE!
Anwendungen Flow Cytometry
Mehr Spezifikationen ansehen

Produkte 1
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
15320690
GREENER_CHOICE
Unterlagen ansehen
Invitrogen™
17-1508-82
100 μg
406.00 CHF
100 Mikrogramm
Alternative Produkte anzeigen
Sparen Sie bis zu 
»
om dit product te kopen Registreer vandaag om een webaccount aan te maken
Beschreibung

Beschreibung

Description: The eBio13G3-19D monoclonal antibody reacts with mouse Ly108, the mouse homologue of human SLAMF6 (signaling lymphocyte activation molecule family member 6). Mouse Ly108 is also known as NTB-A (NK cell, T cell, B cell antigen), and is expressed on NK, T cells, and B cells. Engagement of the Ly108 receptor enhances NK cell activity and expression of IFN-gamma, and contributes to the inability of NK cells to kill Epstein Barr virus-infected B cells in X-linked lymphoproliferative disease. CD4+ T cells from Ly108 knock-out mice exhibit diminished ability to produce IL-4 and defective neutrophil functions. Staining has not revealed any strain differences between C57BL/6 and BALB/c mice. Other strains have not been tested. Applications Reported: This eBio13G3-19D (13G3-19D) antibody has been reported for use in flow cytometric analysis. Applications Tested: This eBio13G3-19D (13G3-19D) antibody has been tested by flow cytometric analysis of mouse splenocytes. This can be used at less than or equal to 0.25 μg per test. A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Excitation: 633-647 nm; Emission: 660 nm; Laser: Red Laser. Filtration: 0.2 μm post-manufacturing filtered.

Ly108, the mouse homologue of human SLAMF6 (signaling lymphocyte activation molecule family member 6), is expressed on NK cells, B cells, and T cells. Engagement of the Ly108 receptor enhances NK cell activity and increases the expression of IFN-gamma. This receptor plays a role in the inability of NK cells to kill Epstein Barr virus-infected B cells in X-linked lymphoproliferative disease. In Ly108 knock-out mice, CD4+ T cells show a diminished ability to produce IL-4 and exhibit defective neutrophil functions, indicating the importance of Ly108 in immune regulation and cellular function. Overall, Ly108 is crucial for modulating immune responses and maintaining effective immune cell activity.
Spezifikation

Spezifikation

Ly-108
0.2 mg/mL
Flow Cytometry
APC
Mouse
RUO
PBS with 0.09% sodium azide; pH 7.2
Q9ET39
30925
Primary
Affinity chromatography
eBio13G3-19D (13G3-19D)
4°C, store in dark, DO NOT FREEZE!
Monoclonal
Liquid
IgG2a κ
Mouse
SLAMF6
Activating NK receptor; CD352; KAL1; KAL1b; KALI; KALIb; Ly108; Lymphocyte antigen 108; natural killer-, T- and B-cell antigen; NK-T-B-antigen; NTBA; NTB-A; NTBA receptor; RGD1561848; SF2000; SLAM family member 6; Slamf6; UNQ6123/PRO20080
SLAMF6
Antibody
Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Product Certifications
Berichtigung von Produktinhalten

Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.

Name des Produkts

Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.

Vielen Dank, dass Sie uns helfen, unsere Website zu verbessern. Ihr Feedback wurde übermittelt